1,022
edits
Changes
Jump to navigation
Jump to search
Line 48:
Line 48: − + − + − + − + + + + + +
→Newer treatments
*Fidazomicin (87.7% success rate vs. 86.8% for vanco, 15.4% recurrence rate)
*Fidazomicin (87.7% success rate vs. 86.8% for vanco, 15.4% recurrence rate)
**Expensive
**Expensive
*Fecal microbiota transplant (83-94% success rate for recurrent COL). Fecal microbiota transplantation restores gut microbiota diversity, with the
*Fecal microbiota transplant (83-94% success rate for recurrent COL).
instillation of donor stool into the gastrointestinal tract of an infected patient, This procedure has had good clinical response without reports of adverse events, for refractory or recurrent COI. The first systematic revien was published in 2911 and
**Fecal microbiota transplantation restores gut microbiota diversity, with the
included 317 patients with recurrent COI treated with fecal microbiota transplantation via enema, nasojejunal-tube/gastroscope or colonoscopy. Clinical resolution occurred in 92% of patients (89% after a single treatment), without serious adverse effects. A recent revien of 536 patients reported a 27% clinical response rate.
instillation of donor stool into the gastrointestinal tract of an infected patient
A randomized trial of fecal microbiota transplantation demonstrated symptom
**This procedure has had good clinical response without reports of adverse events, for refractory or recurrent CDI.
**The first systematic review was published in 2011 and
included 317 patients with recurrent CDI treated with fecal microbiota transplantation via enema, nasojejunal-tube/gastroscope or colonoscopy.
**Clinical resolution occurred in 92% of patients (89% after a single treatment), without serious adverse effects.
**A recent review of 536 patients reported a 27% clinical response rate.
**A randomized trial of fecal microbiota transplantation demonstrated symptom
resolution in 94% of patients who received vancomycin for s days followed by either
resolution in 94% of patients who received vancomycin for s days followed by either
one or two treatments with fecal microbiota transplantation, versus 31% in those
one or two treatments with fecal microbiota transplantation, versus 31% in those